The worldwide chemiluminescence immunoassay market size accounted for $8.37 billion in 2025. • The market is expected to grow to $16.18 billion by 2034. • The market is expected to grow at a solid ...

Abstract: Carcinoembryonic antigen (CEA) is one of the most widely used tumor markers worldwide. A portable system was designed for rapid field specific test of CEA based on immunomagnetic separation ...

Zomedica continues to redefine what is possible in point of care diagnostics with the TRUFORMA biosensor platform ANN ARBOR, MI / ACCESS Newswire / February ...

Fapon, a global leading life sciences company, is showcasing its comprehensive one-stop IVD solutions and sharing the latest ...

The ABBOTT PRISM System is an automated immunoassay analyzer designed to perform Chemiluminescent immunoassay (ChLIA) technology. The ABBOTT PRISM performs batch/continuous access and STAT ...

The enhanced test now provides values for both full-length endogenous ACTH and CLIP (Corticotropin-Like Intermediate Peptide) and calculates a composite value that can be directly compared to results ...

Zomedica continues to redefine what is possible in point of care diagnostics with the TRUFORMA biosensor platform ANN ARBOR, MI / ACCESS Newswire / February 6, 2025 / Zomedica Corp. (NYSE American:ZOM ...